Laparoscopic adrenalectomy for adrenal tumors with endocrine activity: Perioperative management pathways for reduced complications and improved outcomes

Int J Urol. 2023 Oct;30(10):818-826. doi: 10.1111/iju.15218. Epub 2023 Jun 27.

Abstract

The major adrenal tumors with endocrine activity are primary aldosteronism, Cushing's syndrome/mild autonomous cortisol secretion, and pheochromocytoma/paraganglioma. Excessive aldosterone secretion in primary aldosteronism causes cardiovascular, renal, and other organ damage in addition to hypertension and hypokalemia. Cortisol hypersecretion in Cushing's syndrome/mild autonomous cortisol secretion causes obesity, hypertension, impaired glucose tolerance, and cardiometabolic syndrome. Massive secretion of catecholamines in pheochromocytoma/paraganglioma causes hypertension and cerebrocardiovascular disease due to rapid blood pressure fluctuation. Moreover, pheochromocytoma multi-system crisis is a feared and possibly fatal presentation of pheochromocytoma/paraganglioma. Thus, adrenal tumors with endocrine activity are considered an indication for adrenalectomy, and perioperative management is very important. They have a risk of perioperative complications, either due to direct hemodynamic effects of the hormone hypersecretion or due to hormone-related comorbidities. In the last decades, deliberate preoperative evaluation and advanced perioperative management have significantly reduced complications and improved outcomes. Furthermore, improvements in anesthesia and surgical techniques with the feasibility of laparoscopic adrenalectomy have contributed to reduced morbidity and mortality. However, there are still several challenges to be considered in the perioperative care of these patients. There are very few data available prospectively to guide clinical management, due to the rarity of adrenal tumors with endocrine activity. Therefore, most guidelines are based on retrospective data analyses or small case series. In this review, the latest knowledge is summarized, and practical pathways to reduce perioperative complications and improve outcomes in adrenal tumors with endocrine activity are presented.

Keywords: Cushing syndrome; adrenal tumor; adrenalectomy; pheochromocytoma; primary aldosteronism.

Publication types

  • Review

MeSH terms

  • Adrenal Gland Neoplasms* / complications
  • Adrenalectomy / adverse effects
  • Cushing Syndrome* / etiology
  • Cushing Syndrome* / surgery
  • Humans
  • Hydrocortisone
  • Hyperaldosteronism* / complications
  • Hyperaldosteronism* / surgery
  • Hypertension* / etiology
  • Laparoscopy* / adverse effects
  • Paraganglioma* / complications
  • Paraganglioma* / surgery
  • Pheochromocytoma* / surgery
  • Retrospective Studies

Substances

  • Hydrocortisone